Doll, Carolin M. http://orcid.org/0000-0002-4267-1668
Michel, Chantal
Betz, Linda T.
Schimmelmann, Benno G.
Schultze-Lutter, Frauke
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (32003B_135381)
Heinrich-Heine-Universität Düsseldorf
Article History
Received: 10 June 2020
Accepted: 14 May 2021
First Online: 26 May 2021
Declarations
:
: Drs Michel, Schimmelmann, Schultze-Lutter, MSc Doll, and MSc Betz have declared that there are no conflicts of interest in relation to the subject of this study. Dr. Schimmelmann reports and received honoraria and is on the speakers’ board of Takeda (Shire) and Infectopharm.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the ethical committee of the University of Bern (No. 172/09).
: Informed consent was obtained from all individual participants included in the study.